Nisa Investment Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$140K Sell
2,551
-2,021
-44% -$111K ﹤0.01% 1307
2025
Q1
$323K Buy
4,572
+217
+5% +$15.3K ﹤0.01% 1113
2024
Q4
$286K Sell
4,355
-1,830
-30% -$120K ﹤0.01% 1195
2024
Q3
$435K Sell
6,185
-5,575
-47% -$392K ﹤0.01% 1085
2024
Q2
$968K Sell
11,760
-725
-6% -$59.7K 0.01% 887
2024
Q1
$1.09M Sell
12,485
-530
-4% -$46.3K 0.01% 860
2023
Q4
$1.25M Sell
13,015
-400
-3% -$38.6K 0.01% 789
2023
Q3
$1.19M Sell
13,415
-2,200
-14% -$195K 0.01% 820
2023
Q2
$1.35M Hold
15,615
0.01% 793
2023
Q1
$1.52M Sell
15,615
-3,746
-19% -$364K 0.01% 736
2022
Q4
$2M Sell
19,361
-3,830
-17% -$396K 0.02% 737
2022
Q3
$1.97M Buy
23,191
+1,233
+6% +$105K 0.02% 637
2022
Q2
$1.82M Sell
21,958
-3,679
-14% -$305K 0.02% 662
2022
Q1
$1.98M Buy
25,637
+9,465
+59% +$730K 0.01% 667
2021
Q4
$1.43M Sell
16,172
-4,545
-22% -$403K 0.01% 730
2021
Q3
$1.6K Sell
20,717
-213
-1% -$16 0.01% 763
2021
Q2
$1.75K Buy
20,930
+300
+1% +$25 0.01% 754
2021
Q1
$1.56K Buy
20,630
+300
+1% +$23 0.01% 790
2020
Q4
$1.78M Sell
20,330
-3,739
-16% -$328K 0.01% 725
2020
Q3
$1.83M Sell
24,069
-14,971
-38% -$1.14M 0.01% 625
2020
Q2
$4.82M Buy
39,040
+5,531
+17% +$682K 0.04% 353
2020
Q1
$2.83M Buy
33,509
+4,800
+17% +$406K 0.03% 432
2019
Q4
$2.43M Buy
28,709
+2,474
+9% +$209K 0.02% 578
2019
Q3
$1.77M Sell
26,235
-4,068
-13% -$274K 0.02% 689
2019
Q2
$2.6M Sell
30,303
-4,270
-12% -$366K 0.02% 545
2019
Q1
$3.07M Sell
34,573
-459
-1% -$40.8K 0.03% 491
2018
Q4
$2.98M Sell
35,032
-1,100
-3% -$93.7K 0.03% 450
2018
Q3
$3.5M Buy
36,132
+17,612
+95% +$1.71M 0.03% 468
2018
Q2
$1.75M Buy
18,520
+7,000
+61% +$660K 0.02% 643
2018
Q1
$934K Buy
11,520
+750
+7% +$60.8K 0.01% 842
2017
Q4
$960K Sell
10,770
-50
-0.5% -$4.46K 0.01% 847
2017
Q3
$1.01M Buy
10,820
+3,400
+46% +$316K 0.01% 819
2017
Q2
$674K Hold
7,420
0.01% 924
2017
Q1
$651K Hold
7,420
0.01% 944
2016
Q4
$615K Sell
7,420
-2,200
-23% -$182K 0.01% 970
2016
Q3
$890K Buy
9,620
+2,200
+30% +$204K 0.01% 823
2016
Q2
$577K Hold
7,420
0.01% 934
2016
Q1
$612K Sell
7,420
-1,900
-20% -$157K 0.01% 923
2015
Q4
$976K Buy
9,320
+40
+0.4% +$4.19K 0.01% 749
2015
Q3
$977K Sell
9,280
-400
-4% -$42.1K 0.01% 741
2015
Q2
$1.32M Sell
9,680
-100
-1% -$13.7K 0.02% 691
2015
Q1
$1.22M Buy
9,780
+900
+10% +$112K 0.02% 726
2014
Q4
$803K Sell
8,880
-400
-4% -$36.2K 0.01% 862
2014
Q3
$670K Hold
9,280
0.01% 918
2014
Q2
$577K Buy
9,280
+60
+0.7% +$3.73K 0.01% 988
2014
Q1
$629K Hold
9,220
0.01% 955
2013
Q4
$649K Hold
9,220
0.01% 945
2013
Q3
$665K Hold
9,220
0.01% 916
2013
Q2
$514K Buy
+9,220
New +$514K 0.01% 997